Circulating Fibroblast Growth Factor 21 is Associated with Diastolic Dysfunction in Heart Failure Patients with Preserved Ejection Fraction-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Circulating Fibroblast Growth Factor 21 is Associated with Diastolic Dysfunction in Heart Failure Patients with Preserved Ejection Fraction

Published:2016-09-21 Issue:1 Volume:6 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Chou Ruey-Hsing,Huang Po-Hsun,Hsu Chien-Yi,Chang Chun-Chin,Leu Hsin-Bang,Huang Chin-Chou,Chen Jaw-Wen,Lin Shing-Jong

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep33953.pdf

Reference38 articles.

1. Bhatia, R. S. et al. Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med. 355, 260–269 (2006).

2. Owan, T. E. et al. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med. 355, 251–259 (2006).

3. Planavila, A., Redondo-Angulo, I. & Villarroya, F. Fgf21 and cardiac physiopathology. Front Endocrinol. 6, 133 (2015).

4. Zhang, J. & Li, Y. Fibroblast growth factor 21, the endocrine fgf pathway and novel treatments for metabolic syndrome. Drug Discov Today. 19, 579–589 (2014).

5. Tanajak, P., Chattipakorn, S. C. & Chattipakorn, N. Effects of fibroblast growth factor 21 on the heart. J Endocrinol. 227, R13–30 (2015).

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Correlation of circulating fibroblast growth factor 21 levels with inflammatory factors and the degree of coronary artery stenosis in patients with acute myocardial infarction;Cytokine;2024-06

2. Fibroblast growth factor 21 (FGF21): diagnostic, prognostic and therapeutic aspects in heart failure. A review;Consilium Medicum;2024-05-02

3. Methods to predict heart failure in diabetes patients;Expert Review of Endocrinology & Metabolism;2024-04-15

4. A genetic mouse model of lean-NAFLD unveils sexual dimorphism in the liver-heart axis;Communications Biology;2024-03-22

5. Effects of Empagliflozin‐Induced Glycosuria on Weight Gain, Food Intake and Metabolic Indicators in Mice Fed a High‐Fat Diet;Endocrinology, Diabetes & Metabolism;2024-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3